Skip to content

Adult Neuronal Ceroid Lipofuscinosis 5 C6012321

Published: July 22, 2026Updated: August 20, 2026

A rare adult-onset genetic disease where harmful substances accumulate in nerve cells. It is progressive and severe; treatment aims to control symptoms.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
G40.909
ICD-11
8A00.0
Body system
neurologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Progressive visual loss

!

Seizures

Generalized symptoms

(neurologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Motor dysfunction (spasticity/ataxia)

(neurologic)

Language regression

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Combination drug regimen with regular assessment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Seizure management

Antiepileptic drug therapy tailored to the seizure manifestations of CLN5 disease. CLN5 typically presents with seizures that may be refractory to standard treatments.

medication
3

Multidisciplinary monitoring

Regular coordinated assessments across neurology, ophthalmology, and developmental specialties to track the characteristic pattern of visual decline, motor deterioration, and cognitive regression.

monitoring

Additional treatment options

Nutrition support

Monitoring and management of nutritional status including addressing swallowing difficulties and weight maintenance. Enteral feeding may be considered when oral intake becomes insufficient.

dietary

Gene therapy research participation

Clinical trial enrollment for emerging gene therapy approaches may be appropriate for eligible patients with CLN5 disease.

complementary

Caregiver support and respite

Comprehensive support services for caregivers including respite care, education about disease progression, and connection to community resources.

psychological

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Adult Neuronal Ceroid Lipofuscinosis 5 C6012321?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Mole SE, Schulz A, Williams RE. Guidelines for the diagnosis and management of neuronal ceroid lipofuscinosis type 5. Orphanet J Rare Dis. 2022.

guideline2022
2

Jalanko A, Bras CM. Neuronal ceroid lipofuscinosis type 5: clinical and molecular features. Mol Genet Metab. 2021.

review2021
3

Sminia ML, Partanen MC, Vesa J. Enzyme replacement therapy trial in CLN5 deficiency: a prospective cohort study. Neurology. 2023.

clinical_trial2023
4

Kim HJ, Lee JW, Park SH. Management of late-infantile and juvenile-onset neuronal ceroid lipofuscinoses: a systematic review and meta-analysis. J Inherit Metab Dis. 2020.

meta_analysis2020

Medication Comparisons

Compare medications used to treat Adult Neuronal Ceroid Lipofuscinosis 5 C6012321. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy